Terms: = Endocrine gland cancer AND FGFR1, CEK, 2260, ENSG00000077782, P11362, FLT2, CD331, H3, HBGFR, FGFBR, H5, KAL2, H2, BFGFR, N-SAM, H4 AND Prognosis
89 results:
1. Genetic diagnosis of endocrine disorders in Cyprus through the Cyprus Institute of Neurology and Genetics: an ENDO-ERN Reference Center.
Neocleous V; Fanis P; Toumba M; Skordis N; Phylactou LA
Orphanet J Rare Dis; 2024 Apr; 19(1):167. PubMed ID: 38637882
[TBL] [Abstract] [Full Text] [Related]
2. Interplay between B7-H3 and HLA class I in the clinical course of pancreatic ductal adenocarcinoma.
Cattaneo G; Ventin M; Arya S; Kontos F; Michelakos T; Sekigami Y; Cai L; Villani V; Sabbatino F; Chen F; Sadagopan A; Deshpande V; Moore PA; Ting DT; Bardeesy N; Wang X; Ferrone S; Ferrone CR
Cancer Lett; 2024 Apr; 587():216713. PubMed ID: 38364961
[TBL] [Abstract] [Full Text] [Related]
3. EZH2-mediated development of therapeutic resistance in cancer.
Kaur P; Shankar E; Gupta S
Cancer Lett; 2024 Apr; 586():216706. PubMed ID: 38331087
[TBL] [Abstract] [Full Text] [Related]
4. Proteomic profiling of ovarian clear cell carcinomas identifies prognostic biomarkers for chemotherapy.
Yue L; Gong T; Jiang W; Qian L; Gong W; Sun Y; Cai X; Xu H; Liu F; Wang H; Li S; Zhu Y; Zheng Z; Wu Q; Guo T
Proteomics; 2024 Mar; 24(6):e2300242. PubMed ID: 38171885
[TBL] [Abstract] [Full Text] [Related]
5. Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-agent fibroblast growth factor receptor-specific inhibitors in pancreatic cancer.
Lin Q; Serratore A; Perri J; Roy Chaudhuri T; Qu J; Ma WW; Kandel ES; Straubinger RM
Br J Pharmacol; 2024 May; 181(9):1383-1403. PubMed ID: 37994108
[TBL] [Abstract] [Full Text] [Related]
6. Nomogram for preoperative estimation risk of lateral cervical lymph node metastasis in papillary thyroid carcinoma: a multicenter study.
Zhu J; Chang L; Li D; Yue B; Wei X; Li D; Wei X
Cancer Imaging; 2023 Jun; 23(1):55. PubMed ID: 37264400
[TBL] [Abstract] [Full Text] [Related]
7. NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer.
Xiong Q; Zhou Y; Zhang S; Zhang Y; Xu Y; Yang Y; Zhou C; Zeng Z; Han J; Zhu Q
Cancer Med; 2023 May; 12(9):10961-10978. PubMed ID: 37062069
[TBL] [Abstract] [Full Text] [Related]
8. Evaluation of serum B7-H3 expression, ultrasound and clinical characteristics to predict the risk of cervical lymph node metastases in papillary thyroid carcinoma by nomogram.
Huang Y; Huang Z; Cai H; Zhuge L; Wang S; Yan D; Zhang X; An C; Niu L; Li Z
J Clin Lab Anal; 2023 Jan; 37(1):e24811. PubMed ID: 36525343
[TBL] [Abstract] [Full Text] [Related]
9. Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma.
Chen X; Ma H; Mo S; Yu S; Lu Z; Chen J
Front Immunol; 2022; 13():1027459. PubMed ID: 36325339
[TBL] [Abstract] [Full Text] [Related]
10. Deficiency of tumor-expressed B7-H3 augments anti-tumor efficacy of anti-PD-L1 monotherapy rather than the combined chemoimmunotherapy in ovarian cancer.
Huang M; Luo J; Ji X; Hu M; Xue Y; Liu Q
Pharmacol Res; 2022 Dec; 186():106512. PubMed ID: 36272639
[TBL] [Abstract] [Full Text] [Related]
11. Retinoic acid receptor gamma is required for proliferation of pancreatic cancer cells.
Ji K; Dou W; Zhang N; Wen B; Zhong M; Zhang Q; Xu S; Zhou J; Liu J
Cell Biol Int; 2023 Jan; 47(1):144-155. PubMed ID: 36183362
[TBL] [Abstract] [Full Text] [Related]
12. Analysis of the OX40/OX40L immunoregulatory axis combined with alternative immune checkpoint molecules in pancreatic ductal adenocarcinoma.
Chen X; Ma H; Mo S; Zhang Y; Lu Z; Yu S; Chen J
Front Immunol; 2022; 13():942154. PubMed ID: 35936015
[TBL] [Abstract] [Full Text] [Related]
13. Histone deacetylase inhibitor, panobinostat, exerts anti-proliferative effect with partial normalization from aberrant epigenetic states on granulosa cell tumor cell lines.
Hazama Y; Tsujioka T; Kitanaka A; Tohyama K; Shimoya K
PLoS One; 2022; 17(7):e0271245. PubMed ID: 35802681
[TBL] [Abstract] [Full Text] [Related]
14. Immune Checkpoint Protein Expression Defines the prognosis of Advanced Thyroid Carcinoma.
Luo Y; Yang YC; Shen CK; Ma B; Xu WB; Wang QF; Zhang Y; Liao T; Wei WJ; Wang Y
Front Endocrinol (Lausanne); 2022; 13():859013. PubMed ID: 35574031
[TBL] [Abstract] [Full Text] [Related]
15. Prognostic values of B7-H3, B7-H4, and HHLA2 expression in human pancreatic cancer tissues based on mIHC and spatial distribution analysis.
Zhu Y; Chen J; Liu Y; Zheng X; Feng J; Chen X; Jiang T; Li Y; Chen L
Pathol Res Pract; 2022 Jun; 234():153911. PubMed ID: 35489125
[TBL] [Abstract] [Full Text] [Related]
16. Co-deficiency of B7-H3 and B7-H4 identifies high CD8 + T cell infiltration and better prognosis in pancreatic cancer.
Si S; Wang L; Cao H; Xu Y; Zhan Q
BMC Cancer; 2022 Feb; 22(1):211. PubMed ID: 35219310
[TBL] [Abstract] [Full Text] [Related]
17. Role of FGF Receptors and Their Pathways in Adrenocortical Tumors and Possible Therapeutic Implications.
Sbiera I; Kircher S; Altieri B; Lenz K; Hantel C; Fassnacht M; Sbiera S; Kroiss M
Front Endocrinol (Lausanne); 2021; 12():795116. PubMed ID: 34956100
[TBL] [Abstract] [Full Text] [Related]
18. B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian cancer Progression.
Miyamoto T; Murakami R; Hamanishi J; Tanigaki K; Hosoe Y; Mise N; Takamatsu S; Mise Y; Ukita M; Taki M; Yamanoi K; Horikawa N; Abiko K; Yamaguchi K; Baba T; Matsumura N; Mandai M
Cancer Immunol Res; 2022 Jan; 10(1):56-69. PubMed ID: 34799346
[TBL] [Abstract] [Full Text] [Related]
19. Soluble B7-H3 in Ovarian cancer and Its Predictive Value.
Kovaleva OV; Belova TP; Korotkova EA; Kushlinskii DN; Gratchev AN; Petrikova NA; Kudlay DA; Kushlinskii NE
Bull Exp Biol Med; 2021 Aug; 171(4):472-474. PubMed ID: 34542756
[TBL] [Abstract] [Full Text] [Related]
20. FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid cancer: Evaluation of the Preclinical Rationale.
Adam P; Kircher S; Sbiera I; Koehler VF; Berg E; Knösel T; Sandner B; Fenske WK; Bläker H; Smaxwil C; Zielke A; Sipos B; Allelein S; Schott M; Dierks C; Spitzweg C; Fassnacht M; Kroiss M
Front Endocrinol (Lausanne); 2021; 12():712107. PubMed ID: 34475850
[TBL] [Abstract] [Full Text] [Related]
[Next]
